Paul M. Garofolo
Vorstandsvorsitzender bei Locus Biosciences, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Dave Ousterout | M | - |
Locus Biosciences, Inc.
 Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | 9 Jahre |
| Bary G. Bailey | M | 65 |
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | - |
| Stuart Peterson | M | - |
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | - |
| Kyle Kurpinski | M | - |
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | - |
| Austin Walne | M | - |
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | - |
| Joseph Nixon | M | - |
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | 7 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Doaa A. Fathallah | F | - | 6 Jahre | |
| Geoffrey Glass | M | 50 |
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | 8 Jahre |
| Joaquín Bautista Viso | M | 81 | 10 Jahre | |
| Paul Levy | M | 76 | 7 Jahre | |
| Brian Shaw | M | 70 | 5 Jahre | |
| Eric Wayne Evans | M | - | 3 Jahre | |
| Peter Thomas Bigelow | M | - | 1 Jahre | |
| Jacqueline Le Saux | F | - | 1 Jahre | |
| David Earl Sutin | M | 71 | 3 Jahre | |
| Jennifer Almond | F | - | - | |
| Warren A. Horton | M | 65 | - | |
| Terence S. Novak | M | 67 | 2 Jahre | |
| Derek Watchorn | M | 81 | 16 Jahre | |
| James Mullen | M | 65 | 6 Jahre | |
| Ramsey A. Frank | M | 63 | 5 Jahre | |
| Nick DiPietro | M | - | 20 Jahre | |
| Nick Taylor | M | - |
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | - |
| Nicholas O'Leary | M | 41 | - | |
| Doug Mendenhall | M | - | 1 Jahre | |
| Mark James Kontny | M | - | 2 Jahre | |
| Charles Gersbach | M | - |
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | - |
| Chase Beisel | M | - |
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | - |
| Gregory J. Davis | M | 59 | 2 Jahre | |
| Dean Frederick Wilson | M | - | 6 Jahre | |
| Gary L. Shope | M | - | 3 Jahre | |
| Harry Gill | M | 63 | 4 Jahre | |
| Jonathan Arnold | M | 59 | 14 Jahre | |
| Rodolphe Barrangou | M | - |
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | - |
| Edgar Jaynes | M | - | 4 Jahre | |
| Antonella Mancuso | F | 54 | 12 Jahre | |
| Marvin Faber | M | - | 11 Jahre | |
| Michael J. Lehmann | M | 61 | - | |
| Aqeel Ahmed Fatmi | M | 73 | 1 Jahre | |
| Wesley Wheeler | M | 68 | 3 Jahre | |
| Norman Barras | M | 69 | 9 Jahre | |
| George Voorheis | M | 70 | - | |
| Thomas S. Taylor | M | - | 4 Jahre | |
| Shabbir Anik | M | 71 | 9 Jahre | |
| Roy Thomas Graydon | M | 62 | - | |
| Stuart R. Grant | M | 69 | 2 Jahre | |
| John H. Bell | M | - | 2 Jahre | |
| Claudio F. Bussandri | M | 76 | 1 Jahre | |
| Michael Lytton | M | 67 | 3 Jahre | |
| Peter A. W. Green | M | 86 | 13 Jahre | |
| Paul W. Currie | M | 65 | 1 Jahre | |
| Livia M. Maduri | F | - | 8 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Kanada | 42 | 80,77% |
| Vereinigte Staaten | 11 | 21,15% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Paul M. Garofolo
- Persönliches Netzwerk
